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Introduction
The issue of how crosslinking of membrane determinants induces
linkage to the cytoskeleton dates back to the original patching and
capping observations (Raff et al., 1970) and the ideas of Singer and
colleagues (Holifield et al., 1990; Singer, 1977; Singer and Nicolson,
1972). The problem is more intriguing when we consider that even
outer-leaflet lipids and glycosylphosphatidylinositol (GPI)-anchored
proteins (GPIAPs), when crosslinked, undergo patching and capping
(Holifield et al., 1990; Schroit and Pagano, 1981), implying a robust
linkage of the cluster to the retrograde-flowing cytoskeleton under
the plasma membrane. We know that ligated GPIAPs can signal
across the plasma membrane (Rege and Hagood, 2006). For
example, antibody binding to GPIAPs induces an association with
Src-family kinases (SFKs) (Stefanova et al., 1991). Crosslinking
Thy-1, a GPIAP on T cells, results in mitogenesis (Kroczek et al.,
1986; Zhang et al., 1992) and group B coxsackieviruses initiate
infection by binding to and clustering decay-accelerating factor
(DAF), the GPIAP co-receptor, on the apical surface of epithelial
cells (Coyne and Bergelson, 2006).
Previously, we showed that a novel feature of single-particle
tracking (SPT) trajectories of crosslinked membrane proteins could
be used as a nano-assay to dissect how the linkage of certain GPIAPs
and transmembrane proteins to the cytoskeleton is regulated (Chen
et al., 2006). In that study, 40-nm gold particles were used to form
clusters of GPI-anchored proteins that were much smaller than the
typical size of patched antigen observed by immunostaining
(Holifield et al., 1990). The crosslinking induced by the gold particle
produced a nanoscale phenotype in the SPT trajectories in which
the particle seemed to stop for periods of milliseconds to seconds;
we termed this signature transient anchorage (TA). We found that
TA for GPIAPs depended on SFKs, PI3 kinase, cholesterol and
caveolin-1. By contrast, a transmembrane protein, the cystic fibrosis
transmembrane conductance regulator (CFTR), also exhibited TA
but this was strictly dependent on its C-terminal PDZ-binding
domain, and only slightly dependent on SFKs and cholesterol. This
strong dependence of CFTR anchorage on linkage to the
cytoskeleton was also reported by Verkman and colleagues (Haggie
et al., 2006). Recently, Kusumi and co-workers reported a
comprehensive study on the transient confinement of CD59, a
GPIAP. This study concluded that the aggregated CD59 molecules
can undergo a temporary confinement that requires cholesterol, an
intact actin-filament network and Gi2-dependent SFK activation
(Suzuki et al., 2007b). For GPIAPs, the phenomena of TA and
stimulation-induced temporary arrest of lateral diffusion (STALL)
(Suzuki et al., 2007a; Suzuki et al., 2007b) bear marked similarities
in their requirements for clustering, cholesterol and SFKs, although
It remains unclear how GPI-anchored proteins (GPIAPs),
which lack cytoplasmic domains, transduce signals triggered
by specific ligation. Such signal transduction has been
speculated to require the ligated GPIAP to associate with
membrane-spanning proteins that communicate with obligate
cytoplasmic proteins. Transient anchorage of crosslinked
proteins on the cell surface was previously characterized by
single-particle tracking, and temporary association with the
actin cytoskeleton was hypothesized to cause regulated
anchorage. GPIAPs, such as Thy-1, require clustering,
cholesterol and Src-family kinase (SFK) activity to become
transiently anchored. By contrast, a transmembrane protein,
the cystic fibrosis transmembrane conductance regulator
(CFTR), which has a PDZ-binding motif in its cytoplasmic C-
terminus that binds the ERM adaptor EBP50, exhibits
anchorage that strictly requires EBP50 but has little dependence
on cholesterol or SFK. We hypothesized that a transmembrane
protein would be required to mediate the linkage between Thy-
1 and the cytoskeleton. Here, we present evidence, obtained by
shRNA knockdown, that the transmembrane protein Csk-
binding protein (CBP) plays an obligatory role in the transient
anchorage of Thy1. Furthermore, either a dominant-negative
form of CBP that did not bind EBP50 or a dominant-negative
EBP50 drastically reduced transient anchorage of Thy-1,
indicating the involvement of this adaptor. Finally, we speculate
on the role of phosphorylation in the regulation of transient
anchorage.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/122/21/3966/DC1
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3967CBP, a GPIAP-cluster sensor
the SPT-detection algorithms are different so the relative abundances
of each immobilization type might differ.
A key issue is how these clustered GPIAPs are linked to the
cytoskeleton and how this linkage is regulated. Simons and Toomre
suggested that crosslinking of receptors might be a key to effecting
signal transduction by either altering partitioning into existing raft
domains or bringing smaller rafts together (Simons and Toomre,
2000). The Kusumi group (Kusumi et al., 2004; Suzuki et al., 2007b)
suggested that the mechanism involves the binding of GPIAP
clusters to actin filaments indirectly through an unspecified
transmembrane protein and/or through actin-associated membrane
microdomains. The working hypothesis that we proposed (Chen et
al., 2006) invoked the former alternative, but the key transmembrane
protein was not identified. In this study, we tested that hypothesis
and identified a candidate for the unknown transmembrane protein
either acting alone or as component of a required transmembrane
protein complex.
The Csk-binding protein (CBP), also known as PAG
(phosphoprotein associated with glycosphingolipid-enriched
microdomains), is a ~45 kDa (calculated weight, but which migrates
on gels as a 70-85 kDa protein) transmembrane adaptor protein
having a very small ectodomain and a large cytoplasmic domain
that contains ten tyrosine residues (Horejsi et al., 2004). The protein
binds a cytoplasmic protein tyrosine kinase (C-terminal Src kinase;
CSK), which then negatively regulates SFKs (Brdickova et al., 2001;
Brdicka et al., 2000). Photobleaching experiments on T cells
suggest that the reduced mobility of GPIAP-enriched lipid rafts
(microdomains), containing Fyn-phosphorylated CBP (Yasuda et
al., 2002), is caused by the linkage of CBP-EBP50-ERM complexes
to the cytoskeleton (Itoh et al., 2002). Moreover, CBP was
previously shown to be associated with Thy-1 clusters upon
phosphorylation and/or pervanadate treatment (Durrheim et al.,
2001).
On the basis of these results, we hypothesized (Chen et al., 2006)
that CBP might be the transmembrane phosphoprotein or part of a
transmembrane complex that recognizes in some way clustered
GPIAPs and permits linkage of the cluster to the underlying
cytoskeleton. We also postulated that phosphatase activity would
be required to release the TA state. To test this hypothesis, we
examined the involvement of CBP in TA when Thy-1 molecules
are clustered by quantum dots (Qdots) on the fibroblast membrane.
We show that CBP is indispensable for the TA of Thy1; this
observation suggests that CBP is at least part of a transmembrane
‘cluster sensor’ of the ‘Protein X’ type invoked by Singer more
than 30 years ago (Singer, 1977). The involvement of CBP was
further supported by the immunostaining experiments in which
anchored GPIAP clusters labeled with Qdots, and trapped by
pervanadate treatment, were always colocalized with CBP staining.
Furthermore, the presence of dominant-negative forms of ERM-
binding protein 50 (EBP50) – a cytoskeletal adaptor protein that is
invoked to anchor GPIAP clusters – and a CBP that cannot bind
EBP50 drastically reduced TA of Thy-1.
Results
In this study, we first show that Qdot-based SPT reproduces the
results from gold-particle-based SPT; fluorescent Qdots were
employed to make two-color colocalization studies feasible. Next,
we show that CBP is an obligatory component for TA of Thy-1.
Finally, we show that CBP binds to the adaptor EBP50 to achieve
TA and contrast this behavior to that of CFTR, which also links to
the cytoskeleton via EBP50.
Qdot-based SPT reproduces the results from gold-particle-
based SPT
To explore the correlative relationship between TA and different
putative components of the TA complex, it is important to have the
capability to visualize signals from different components in the same
experiment. For this reason we switched from using video-enhanced
bright-field microscopy to visualize gold particles to fluorescence
microscopy to visualize Qdots for SPT experiments.
Therefore, previous experiments that used gold particles (Chen
et al., 2006) were repeated using Qdots to cluster Thy-1. As shown
in Fig. 1A, Thy-1 molecules, when clustered by the maximal
crosslinking method (Fig. 1B, left) or by pre-assembled complexes
(Fig. 1B right), exhibited similar degrees of TA; by contrast, little
TA was observed when Thy-1 was not deliberately crosslinked.
These results demonstrate that both Qdots and gold particles are
effective in generating the TA phenotype. The diffusion coefficients
from Qdot- and gold-particle-based SPT both were in the order of
510–2 m2/second (supplementary material Table S1); note that
these values are similar to those reported by (Suzuki et al., 2007a)
for gold-mediated crosslinking of CD59, another GPIAP. Although
the overall distribution of anchorage times was similar, the
distribution of stopping times detected with Qdots was shifted
towards the right so that the shortest anchorage times were longer
for Qdots than gold particles (~700 ms as compared with ~300 ms;
compare Fig. 1C with 1D). This effect might be explained by the
stronger affinity between biotin and streptavidin (Kd~10–15 M–1),
the former labeling the antibody against surface molecules and latter
coating the Qdot surface, as compared with the situation for gold-
particle labeling. In the case of gold, the affinity between biotin-
labeled antibody binding Thy-1 and anti-biotin antibody coating
the gold surface is weaker (Kd~10–10 M–1 or less) (Van Regenmortel,
1998) than the stronger affinity provided by Qdot-based pre-
assembled complexes. Thus, the higher affinity of the Qdot label
might contribute to slightly denser clustering of Thy-1, leading to
longer minimum TA times. Additionally, the higher maximum
valency between biotin and streptavidin (4:1) than between biotin
and anti-biotin antibody (2:1) might also play a role.
Overall, the fact that TA can be induced by preassembled
complexes illustrates that aggregation on this scale [less than 135
molecules (see Chen et al., 2006)] is enough to trigger a signal for
TA to occur. Given the TA-inducing capacity of preassembled Qdot
complexes, as well as the similarity of the behavior between gold
particles and Qdots with respect to TA, we employed preassembled
Qdot complexes throughout this study to cluster Thy-1 molecules
for subsequent SPT experiments.
CBP plays a role in transiently anchoring Thy-1 clusters to the
actin cytoskeleton
To test the role of CBP in TA of Thy-1 clusters, short hairpin RNA
(shRNA) for CBP was introduced into murine 3T3 fibroblasts and
successfully reduced expression of CBP in whole-cell lysates (Fig.
2B, left panel). Knockdown was estimated to be 70-80% based on
analysis by ImageQuant software. In CBP-silenced cells (Fig. 2B),
TA was significantly reduced compared with control experiments,
in which either non-transfected 3T3 cells or 3T3 cells expressing
a random DNA sequence were examined (Fig. 2A, left).
Transfection with a random-sequence control shRNA did not affect
CBP expression (supplementary material Fig. S1B). Moreover, CBP
knockdown by shRNA could be partially rescued by transfecting
knockdown mouse 3T3 cells with full-length human CBP (Fig. 2A,












serves as a control). By contrast, anchorage of CFTR, a
transmembrane protein, was permanent for most CFTR-bound
Qdots (Table 1) and was not affected by CBP abundance. Thus,
these results indicate that CBP mediates TA of Thy-1 clusters but
is not required for anchorage of CFTR.
We previously postulated that phosphatase activity would be
required to release TA (Chen et al., 2006). To test this hypothesis,
we examined Qdots and CBP immunofluorescence after treating
C3H cells with pervanadate, a broad-spectrum membrane-permeable
phosphatase inhibitor. On the basis of previous literature (Brdickova
et al., 2001; Brdicka et al., 2000; Durrheim et al., 2001; Itoh et al.,
2002; Yasuda et al., 2002), the rationale was that CBP and adaptors
in the postulated linkage between clustered Thy-1 and the
cytoskeleton, among other phosphoproteins, would remain
phosphorylated, trapping the TA state. Indeed, pervanadate
treatment, which preserves CBP phosphorylation (supplementary
material Fig. S1A), resulted in prolonged anchorage, which lasted
more than 1 minute (see supplementary material Movie 1A, in which
Journal of Cell Science 122 (21)
two particles freely move before pervanadate treatment, and Movie
1B, in which one particle in the lower right is representative of the
pervanadate-immobilized particles). Moreover, Qdots, which
generated and bound to Thy-1 clusters, were found exclusively
within regions containing phosphorylated CBP (Fig. 2C); by
contrast, such a correlation was not observed in control cells (Fig.
2D). Among six cells examined after pervanadate treatment, 255
out of 279 Qdots were counted as being encompassed by CBP
staining. In control C3H cells, in which not all Thy-1 clusters would
be expected to be undergoing TA at the time of fixation, only 19
out of 276 Qdots were counted as being encompassed by CBP
staining in the four cells examined. The importance of
phosphorylation for CBP function in TA was also demonstrated by
the fact that TA in CBP-knockdown cells could not be restored by
pervanadate treatment (Fig. 2A, left panel); this suggests that TA
requires phosphorylation of CBP and/or the phosphorylation of
another protein(s) whose phosphorylation status regulates CBP
function.
Fig. 1. Single-particle tracking (SPT) using quantum dots (Qdots) gives comparable results to gold-particle-based SPT. (A)TA of Thy-1 clusters labeled by Qdots
(white bars) in C3H cells was induced by (B, left) the maximal crosslinking [crslk; see procedure 1 in Materials and Methods; the number of trajectories (n)70]
scheme or by (B, right) preassembled complexes (prcmlx; see procedure 2 in Materials and Methods; n78), whereas the control observation was made in cells
treated without crosslinking tertiary antibody (ctrl; n60). The Qdot-based SPT results are similar to the results previously published for gold-particle-based SPT
(hatched bars; n69 for ctrl, n90 for crslk and n92 for prcmplx) (Chen et al., 2006). (C,D)Thy-1-cluster-bound Qdots underwent TA ranging from ~700 ms to
more than 7 seconds (C) and exhibited a bi-exponential decay in TA duration distribution, similar to the results previously obtained in gold-particle-based SPT (D).
Table 1. CFTR is immobile when the ERM-binding capacity of EBP50 is intact and CFTR anchorage is independent of CBP 
shRNA-CBP (3T3) Random sequence (3T3) WT-EBP50 (C3H) EGFP–DN-EBP50 (C3H) 
Degree of immobility* (%) >99 >99 >99 2.0 
*The movement of CFTR-bound Qdots was recorded for 1 minute and the mobility was assessed by visual inspection and TA detection software if not
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The adaptor EBP50 facilitates TA by linking Thy-1 clusters to
the actin cytoskeleton via CBP
In our previous paper (Chen et al., 2006), we suggested that an
adaptor, such as EBP50, might be involved in TA, based on literature
showing that it can bind to phosphorylated CBP (Brdickova et al.,
2001; Itoh et al., 2002) and its demonstrated role in transiently
anchoring CFTR. It is well known that CFTR and a number of
other transmembrane proteins, such as the renal brush border
membrane Na(+)-H+ exchanger (Weinman et al., 1995), the 2-
adrenergic receptor (Hall et al., 1998), the G-protein-coupled
receptor kinase-6A (Hall et al., 1999) and the Yes-associated
protein 65 (Mohler et al., 1999), are anchored to the actin
cytoskeleton through EBP50 (Short et al., 1998) and proteins of
the ERM family. Recently, the B-cell receptor has been shown to
undergo an ezrin-regulated linkage to the cytoskeleton (Gupta et
al., 2006) that also seems to be mediated by CBP.
To explore this facet of TA, wild-type (EGFP–WT-EBP50) and
a dominant-negative mutant (EGFP–DN-EBP50) were
overexpressed to evaluate EBP50 involvement in TA. EGFP–DN-
EBP50 competes with endogenous EBP50 to occupy the PDZ-
binding motif of interacting proteins but cannot bind ERM proteins,
thereby breaking the adaptor linkage (Fouassier et al., 2000; Reczek
et al., 1997). As a result, any event relying on EBP50 would be
disrupted by overexpression of EGFP–DN-EBP50. C3H cells
transfected with EGFP–DN-EBP50 were selected with neomycin
(0.5 mg/ml) for SPT (supplementary material Fig. S2). TA of Thy-
1 clusters induced by preassembled complexes was significantly
suppressed in EGFP–DN-EBP50-overexpressed cells compared
with control cells or EGFP–WT-EBP50-overexpressed cells (Fig.
3; supplementary material Movie 2). It was observed that, in
EGFP–WT-EBP50-overexpressed cells, TA was not increased
significantly, implying that the limiting factor for TA was not the
quantity of EBP50 molecules available.
The importance of the affinity of CBP for EBP50 was
demonstrated using a mutant form of CBP, CBPDTRL, in which a
C-terminal sequence (TRL) of CBP was deleted with the
consequence that the binding to the N-terminal PDZ domain(s) of
EBP50 to CBP was abrogated (Brdickova et al., 2001). In cells
transfected with CBP shRNA, the expression of full-length human
CBP could restore TA to a significant level as noted above (Fig.
2A); by contrast, if CBPDTRL was used instead, the TA level
remained negligible (Fig. 2A, right panel). CBP silencing and
CBPDTRL rescue were verified using western blots (Fig. 2B, right
panel).
It is instructive to compare the differences in the lateral-mobility
characteristics between a GPIAP and a transmembrane protein,
Fig. 2. The transmembrane protein CBP mediates TA of Thy-1. (A, left) After shRNA for CBP was introduced in 3T3 cells, TA of Thy-1 clusters was markedly
reduced (n57) compared with control 3T3 cells (n40) or cells transfected with a random DNA sequence (n79). Without CBP, there was minimal TA after
pervanadate treatment (n33). After CBP shRNA was introduced, 3T3 cells were infected with retroviral viruses coding for either full-length CBP (CBPFL, n49)
or a CBP construct with the TRL deletion (CBPDTRL, n55), which does not bind EBP50 (right). (A, right) Compared with CBP knockdown cells, TA was
partially rescued by full-length CBP, whereas almost no rescue was achieved with the TRL mutant. The negative control was mock transfection in the CBP-
knockdown cells (n30). (B)Blots show that CBP was knocked down in whole-cell lysates (WCL) and the effective restoration of CBPFL and CBPTRL in the
shRNA-infected cells compared with the mock transfection. Molecular masses are indicated in kDa. (C)TA of Thy-1 clusters on C3H was prolonged by
pervanadate treatment to over 1 minute. Every Thy-1-cluster-bound Qdot (red) was seen to be accompanied by proximate CBP staining (green). The inset in the
upper left corner is the magnified view of the area surrounded by the white line. (D)In control C3H cells, in which not all Thy-1 clusters would be expected to be












CFTR. As previously demonstrated, CFTR, when its C-terminus
PDZ-binding motif is present, exhibits spontaneous anchorage by
linking to the cytoskeleton through ERM proteins even when the
crosslinking tertiary antibody is absent on the particle employed
for tracking (Chen et al., 2006). CFTR-bound Qdots showed
anchorage in excess of 1 minute in EGFP–WT-EBP50-
overexpressed cells or control C3H cells (supplementary material
Movie 3), consistent with the observations by Haggie et al. (Haggie
et al., 2006). However, overexpressed EGFP–DN-EBP50 interfered
with the binding between CFTR and endogenous EBP50 so that
the prolonged anchorage of CFTR-bound Qdots could not be
detected and only sporadic anchorage was observed (Fig. 3), also
consistent with the observations made by Haggie et al. (Haggie et
al., 2006). It is notable that both Haggie et al. and we observed that,
when Qdots were used as the labeling particle for CFTR, the
anchorage was not transient but more or less permanent. By
contrast, when gold particles were employed to label CFTR, TA
was observed (Chen et al., 2006). The variation in CFTR expression
level, as Haggie et al. have argued, or the intrinsic differences
between Qdots and gold particles and hence the perturbation
imposed by these two ligands, possibly explains mobility differences
observed in these two studies.
Discussion
TA of crosslinked proteins on the cell surface has been previously
characterized by SPT, where temporary association with the actin
cytoskeleton was hypothesized to cause regulated anchorage.
GPIAPs such as Thy-1 require clustering, cholesterol and SFK
activity to become transiently anchored (Chen et al., 2006). In this
paper, we tested the hypothesis that a transmembrane protein would
be required to mediate the linkage between clustered Thy-1 and the
cytoskeleton. We concluded, on the basis of shRNA knockdown
experiments, that, indeed, the transmembrane protein CBP plays an
obligatory role in the TA of Thy-1. This conclusion was supported
by the finding that, upon pervanadate treatment, which inhibited
the release of TA, CPB was colocalized with Thy-1 clusters. Our
results strongly suggest that TA occurs when CBP molecules and
Thy-1 clusters are in close proximity. There are several possibilities
for how this close proximity could come about. For example,
recruitment of Qdot–Thy-1 complexes to CBP or vice versa could
Journal of Cell Science 122 (21)
occur via random, diffusion-driven encounters between the
crosslinked GPIAP and CBP clusters. Alternatively, formation of
a crosslinked CBP aggregate over a CBP protein(s) could place CBP
and Thy-1 in close proximity. We also found that, in addition to
CBP, linkage of Thy-1 clusters to the actin cytoskeleton was
mediated by the adaptor EBP50, because either a dominant-negative
form of CBP that did not bind EBP50 or a dominant-negative EBP50
drastically reduced TA of clustered Thy-1.
Regulation of TA
The results of the pervanadate experiments, in which TA is
converted to permanent anchorage, suggests a phosphorylation-
dephosphorylation mechanism for CBP, and/or associated proteins,
that regulates the linkage of Thy-1 clusters to cytoskeletal adaptors
in a way that leads to the TA phenotype. Dephosphorylation of CBP,
which coincides with its dissociation from lipid rafts (Yasuda et al.,
2002) and from EBP50 (Itoh et al., 2002), could be the point at
which Thy-1 clusters are released from their linkage to the
cytoskeleton. These results are consistent with previous findings
that SFK inhibition or removal reduces TA or STALL significantly
(Chen et al., 2006; Suzuki et al., 2007b). Clearly, such a
phosphorylation-dependent mechanism cannot be proved until the
SFK tyrosine-phosphorylation sites on CBP are fully mapped and
mutated.
Role of the cytoskeletal adaptor EBP50 in anchorage of
membrane proteins
The SPT results for both Thy-1 clusters and CFTR suggest that
EBP50 is responsible for anchoring these entities on the cell surface
to the actin cytoskeleton, albeit with differing degrees of
permanence. In this study, we found that EBP50 can anchor GPIAP
clusters, provided that there is a transmembrane protein (CBP)
available in very close proximity to the cluster for EBP50 to bind
to. It also has been shown that EBP50, with its two PDZ-motif
repeats, PDZ1 and PDZ2, is capable of oligomerization through
PDZ-PDZ interactions forming dimers to tetramers (Fouassier et
al., 2000), all of which could be observed in one cell type. EBP50
retains the ability to bind integral membrane proteins via its PDZ
domains when it is oligomerized (Lau and Hall, 2001; Maudsley
et al., 2000). Such a mechanism offers a plausible explanation for
the discrepancy of the confinement sizes measured by different
groups and in different cells. For example, the Kusumi group has
shown that clusters of CD59, a GPIAP, undergo STALL [such
events are also known as transient confinement zones (TCZs)],
possibly through an actin-anchoring mechanism, but the size of
STALL varies among different cell types (Suzuki et al., 2007a). It
should be noted that we employed a smaller displacement range
used to define TA in our studies as compared with that used by
Suzuki et al. in defining TCZs and/or STALL. The length of the
tethering agent, depending on the number of adaptor proteins
involved, might determine the size of the confinement regions so
that larger adaptor complexes containing multiple proteins would
result in larger confinement zones. It is possible that EBP50
monomers, dimers, trimers and tetramers, with flexible
oligomerization configurations, either through end-to-end (PDZ1-
PDZ2) or lateral (PDZ1-PDZ1, PDZ2-PDZ2) binding (Fouassier
et al., 2000), could interchangeably act as anchorage mediators in
a cell. When the adaptor is a monomer, TA, which has the smallest
confinement size, would be detected. As the number of the EBP50
proteins in the anchoring oligomer grows, larger confinement sizes
would be detected.
Fig. 3. The cytoskeletal adaptor, EBP50, is required for TA of both the GPIAP
Thy-1 and the transmembrane protein CFTR. C3H cells were transfected with
GFP-tagged wild-type EBP50 (EGFP–WT-EBP50, labeled as wt-EBP50) or
dominant-negative EBP (EGFP–DN-EBP50, labeled as dn-EBP50), which
fails to bind to ERM proteins. SPT using preassembled Qdot complexes
showed that cells with overexpressed EGFP–DN-EBP50 had significantly
reduced TA for both Thy-1 clusters (n64) and CFTR molecules (n52)
compared with the control cells (n78) and cells transfected with EGFP–WT-
EBP50 (n58). CFTR-bound Qdots were immobile when EGFP–DN-EBP was
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Comparing the anchorage of clustered GPIAPs and CFTR: a
working hypothesis
It seems that clustered GPIAPs – such as Thy-1 and CD73 (Chen
et al., 2006) – and the non-clustered transmembrane protein CFTR
utilize a common set of molecules for temporary or permanent
anchorage via cytoskeletal association. EBP50 and ERM proteins
are probably among the core components for anchorage (Fig. 4).
To provide a more detailed working hypothesis than previously
proposed (Chen et al., 2006), we postulate that CBP bridges GPIAP
clusters on the outer leaflet of the plasma membrane with
cytoplasmic adaptors. This linkage is hypothesized to be regulated
by SFK phosphorylation of CBP itself and/or an associated
protein(s), designated as KS in Fig. 4. A yet-to-be-identified
phosphatase, whose substrate is CBP and/or an associated protein(s),
could be responsible for reducing the ability of CBP to bind EBP50.
In Qdot-based SPT, CFTR demonstrated much lengthier anchorage
than Thy-1 clusters; this anchorage cannot be categorized as
transient regardless of CBP expression level (Table 1). This indicates
that the associations maintaining the entire adaptor linkage to CFTR
are stable; by contrast, the linkage involving CBP is transient,
perhaps reflecting the phosphorylation-dephosphorylation kinetics
of CBP and/or associated proteins. It will be interesting to see
whether CBP is a prototypical transmembrane cluster-recognition




C3H 10T1/2 murine fibroblasts (American Type Culture Collection, Rockville, MD)
and NIH 3T3 murine fibroblasts with or without various transfections were maintained
in DMEM supplemented with 10% fetal bovine serum, 100 units/ml penicillin and
100 g/ml streptomycin. At 2 to 4 days before an SPT experiment, fibroblasts were
plated into 35-mm glass-bottom Petri dishes at an appropriate cell density that yielded
single cells for SPT measurements. To suppress endogenous CBP expression,
oligonucleotide 5-gatccccGTCCAAGTCCACTTCTG CCt tcaagaga GGCAGAAG -
TG GACT TGGACTtttttggaaa-3 (lowercase bases represent sequences flanking the
insert) was inserted into pSUPER. A pSUPER construct expressing a random siRNA
was used as a control. Constructs were co-transfected with a neomycin-resistance
plasmid into wild-type mouse 3T3 cells using Jet PEI. After 48 hours, transfected
cells were selected with neomycin (1.8 mg/ml) for 5 days. Full-length CBP and TRL-
deleted CBP were introduced into cells by retroviral infection as described previously
(Collin et al., 2007). The silencing of full-length CBP and CBPDTRL-mutant
expressions were validated by western blots (Fig. 2A, insets) on whole-cell lysates
as previously described (Veracini et al., 2008). HA-tagged CFTR protein was
expressed in C3H and 3T3 cells by Lipofectamine transfection. EGFP–WT-EBP50
and EGFP–DN-EBP50, generous gifts from Katherine Karlson (Dartmouth Medical
School, Hanover, NH), were expressed in C3H cells by Lipofectamine transfection
and neomycin (0.5 mg/ml) was used for 3 days to select cells with a high level of
gene expression before SPT.
Qdot conjugation to cells
Procedure 1
Strepavidin-coated Qdot 605 particles (Invitrogen, CA) were diluted in HAMS F12
nutrition mixture (Life Technologies/Gibco-BRL) supplemented with 25 mM HEPES
and 15% serum (HHS). Cells seeded in glass-bottom dishes were first incubated with
biotinylated primary antibodies [monoclonal mouse anti-Thy-1 antibody (clone
19EX5, 0.2 mg/ml)] for 10 minutes, then washed three times with 1 ml HHS. 1 ml
of the solution containing streptavidin-Qdots (0.1 nM) was added and incubated with
cells for 10 minutes at 37°C. Unbound Qdots were removed by washing three times
with 1 ml HH (HHS without serum). For maximal crosslinking, 100 l of the solution
containing tertiary antibodies (goat anti-mouse IgG from Zymed, CA, 0.02 mg/ml)
were added to the cells. Cells were washed three times in HHS to remove unbound
Qdots.
Procedure 2 (preassembled complexes)
Qdots conjugated with antibodies specific to proteins of interest were assembled before
addition to the cells. Preassembled complexes against Thy-1 were made by mixing
10 l streptavidin-Qdots (0.01 M), 2 l of biotinylated goat anti-mouse IgG
antibodies (2 mg/ml) and 20 l of mouse anti-Thy-1 antibodies (15.5 mg/ml) in HHS
solution with a final volume of 200 l, followed by incubating the mixture for 1
hour. Preassembled complexes against HA-CFTR were made by mixing, for 1 hour,
10 l of streptavidin-Qdots (0.01 M) and 10 l of biotinylated mouse anti-HA
antibody (clone 16B12, 0.1 mg/ml; from Covance, NJ) in HHS solution in a final
volume of 200 l. The preassembled complexes then were separated from free
antibodies by centrifugation using 100K nanosep spin-filter (PALL Corporation, MI),
resuspended into 500 l of HHS and added (100 l per treatment) to cells for SPT
experiments as described above for procedure 1. On the basis of the number of
streptavidin conjugated to Qdots (5-10 streptavidins/Qdot) as specified by the
manufacturer (Invitrogen, CA), the added biotinylated goat-anti-mouse IgG antibodies
(2.610–11 mole) were in 15-fold excess over the anti-biotin antibodies coated on
Qdots, and mouse anti-Thy-1 antibodies (10–9 mole) added were in 40-fold excess
over the goat anti-mouse IgG antibodies. For SPT of CFTR, biotinylated anti-HA
antibodies (6.510–12 mole) were added in fourfold excess over the anti-biotin
antibodies coated on Qdots. Particle trajectories were recorded for the following 30
minutes at 37°C in a temperature-controlled chamber on the microscope stage.
Immunofluorescence
Colocalization of crosslinked GPIAPs with CBP after pervanadate
treatment
Crosslinking of Thy-1 molecules was accomplished by incubating cells with
biotinylated anti-Thy-1, streptavidin-Qdots and goat anti-mouse-IgG sequentially as
in procedure 1 above. Cells then were treated with pervanadate (50 M) for 10 minutes.
After washing with PBS, cells were fixed with 4% paraformaldehyde for 10 minutes,
washed three times with PBS and permeabilized with 0.5% Tween 20. Mouse anti-
mouse CBP antibody (Exbio, Czech) and Alexa-Fluor-488-conjugated goat anti-mouse
IgG antibody (Invitrogen, CA) were used to stain CBP inside the cell. Following
extensive washing in PBS, cells were observed using an Olympus IX-81 fluorescence
microscope with a 100 objective and images recorded using a cooled digital 12-
Fig. 4. EBP50-ERM assembly is the
common adaptor complex for both Thy-1
clusters and CFTR. (A)Thy-1 clusters
are generated by tertiary complexes
consisting of streptavidin-coated Qdots
binding biotinylated mouse anti-IgG,
which binds anti-Thy-1 mAb. CBP, alone
or complexed with other unknown Src-
family kinase substrates (KS), is either
recruited into Thy-1 clusters or captured
by Thy-1 clusters. Here, CBP and/or KS
are phosphorylated by SFKs, enabling
CBP to bind to actin filaments via the
EBP50-ERM assembly. The anchorage
can be terminated when either CBP or
the adaptors are dephosphorylated by an
unspecified phosphatase (PTP).
(B)CFTR, containing its own PDZ-
binding motif, binds to actin filaments
via EBP50-ERM spontaneously without
extensive crosslinking. This anchorage is











bit CCD camera (SensiCam, Cooke, OR). As a negative control, cells were pre-fixed
with 4% paraformaldehyde without pervanadate treatment.
Time-lapse Qdot SPT
Qdots bound to cells were imaged using a filter set with an excitation band centered
at 430 nm and an emission band centered at 610 nm (Chroma, VT) using an Olympus
IX-81 fluorescence microscope equipped with a 100 objective. Movies of moving
particles then were recorded with an intensified CCD camera (XG0010, Stanford
Photonics, CA) at video rate (30 frames/second). Recordings typically lasted for 40
seconds and the image stacks were saved in tiff format for later analysis. Tiff stacks
were analyzed employing in-house software incorporating a tracking algorithm written
by Daniel Blair and Eric Dufresne (http://www.seas.harvard.edu/%20projects/
weitzlab/matlab/) that identifies relative changes of Qdot positions on the cell surface
with a precision of ±20 nm. All trajectories were visually inspected to ensure correct
tracking of Qdots.
Data analysis
Trajectories of Qdots obtained from SPT movies were analyzed for TA detection
based on the algorithm developed by Chen et al. (Chen et al., 2006). The analysis
software was designed to detect regions of trajectories where no displacement within
experimental error occurred – as defined by all aspects of measurement stability. By
recording movies of Qdots firmly glued on coverslips using FluorSave reagent
(Calbiochem) and then detecting particle centroids over the time recorded, it was
determined that 95% of centroids fell within ±40 nm along both the x and y axes. A
program was developed to recognize portions from a trajectory as TA events when
the displacement in five successive frames was less than 40 nm in both the x and y
dimensions. Note that TA differs from complete immobilization in which the particle
does not move during the experimental observation time of a particular cell. To further
characterize TA, we defined the relative anchorage time as: sum of durations in which
a single particle is transiently anchored/total time of trajectory.
Image-acquisition descriptions
In Fig. 2C,D and supplementary material Fig. S2, we used a microscope (IX-81;
Olympus) with a 100 NA 1.25 oil-immersion objective (Olympus). FluorSave
reagent (Calbiochem) was used as the imaging medium. EGFP was the fluorochrome
in Fig. 2C,D and Alexa Fluor 488 was employed as the fluorochrome in supplementary
material Fig. S2. Images were captured with a cooled CCD camera (SensiCam, Cooke,
OR) and MetaMorph imaging software (Molecular Devices, CA). MetaMorph was
also used to crop the whole-cell images into small regions and overlay images from
green and red channels for the colocalization assay.
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